Anietie Akpan

United Kingdom

Impact of Alcohol on the Onset and Progression of Alzheimers Disease and Its Related Dementias (R01- Clinical Trial Optional) (RFA-AA-20-006)

GRANT Monday, November 18, 2019- 07:00 National Institute on Alcohol Abuse and Alcoholism National Institute on Aging Issuing IC and partner components intend to commit an estimated total of $3 million to fund six to eight awards. March 24, 2020 Impact of ...

BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (RFA-NS-19-043)

GRANT Monday, November 18, 2019- 07:00 National Institutes of Health The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year. New February 10, 2020, June 10, 2020, October 9, 2020; February 10, ...

BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) (RFA-NS-19-044)

GRANT Monday, November 18, 2019- 07:00 National Institutes of Health The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year. New February 10, 2020; June 10, 2020; October 9, 2020; February 10, ...

Gilda Ennis

University of Wisconsin - Madison
Madison, United States

PAPER Bernardo TC, Beleza J, Rizo-Roca D, Santos-Alves E, Leal C, Martins MJ, Ascensão A, Magalhães J

Physical exercise mitigates behavioral impairments in a rat model of sporadic Alzheimer's disease.

Behav Brain Res. 2020 Feb 3;379:112358. Epub 2019 Nov 13 PubMed: 31733314

PAPER Esmaeili MH, Enayati M, Khabbaz Abkenar F, Ebrahimian F, Salari AA

Glibenclamide mitigates cognitive impairment and hippocampal neuroinflammation in rats with type 2 diabetes and sporadic Alzheimer-like disease.

Behav Brain Res. 2020 Feb 3;379:112359. Epub 2019 Nov 13 PubMed: 31733313

PAPER Dong B, Wu R

Plasma homocysteine, folate and vitamin B12 levels in Parkinson's disease in China: A meta-analysis.

Clin Neurol Neurosurg. 2020 Jan;188:105587. Epub 2019 Nov 4 PubMed: 31733593

PAPER Maass F, Michalke B, Willkommen D, Leha A, Schulte C, Tönges L, Mollenhauer B, Trenkwalder C, Rückamp D, Börger M, Zerr I, Bähr M, Lingor P

Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease.

Neurobiol Dis. 2020 Feb;134:104677. Epub 2019 Nov 13 PubMed: 31733347

PAPER Wolters AF, Moonen AJ, Lopes R, Leentjens AF, Duits AA, Defebvre L, Delmaire C, Hofman PA, van Bussel FC, Dujardin K

Grey matter abnormalities are associated only with severe cognitive decline in early stages of Parkinson's disease.

Cortex. 2020 Feb;123:1-11. Epub 2019 Oct 24 PubMed: 31733342

PAPER Lehfeld H, Stemmler M

The Newly Normed SKT Reveals Differences in Neuropsychological Profiles of Patients with MCI, Mild Dementia and Depression.

Diagnostics (Basel). 2019 Oct 25;9(4) PubMed: 31731518

PAPER Vieira D, Durães J, Baldeiras I, Santiago B, Duro D, Lima M, Leitão MJ, Tábuas-Pereira M, Santana I

Lower CSF Amyloid-Beta1-42 Predicts a Higher Mortality Rate in Frontotemporal Dementia.

Diagnostics (Basel). 2019 Oct 25;9(4) PubMed: 31731494

PAPER Charidimou A, Boulouis G, Greenberg SM, Viswanathan A

Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis.

Neurology. 2019 Dec 10;93(24):e2192-e2202. Epub 2019 Nov 15 PubMed: 31732564

PAPER Wang R, Yang Y, Wang H, He Y, Li C

MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1.

Clin Exp Pharmacol Physiol. 2020 Mar;47(3):372-382. Epub 2019 Dec 15 PubMed: 31732967

PAPER Tripathi MK, Rasheed MS, Mishra AK, Patel DK, Singh MP

Silymarin Protects Against Impaired Autophagy Associated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinsonism.

J Mol Neurosci. 2020 Feb;70(2):276-283. Epub 2019 Nov 15 PubMed: 31732923